Deborah Knobelman

Director of Finance/CFO at

Senti Sub I, Inc.

53 year

65 connections

Health Technology

Finance

Consumer Services

Profile

Deborah A. Knobelman currently works at Senti Sub I, Inc., as Chief Financial Officer & Treasurer from 2021.
Dr. Knobelman also formerly worked at Kronos Bio, Inc., as President, Chief Executive Officer, COO, CFO & CAO from 2024 to 2025, Pfizer Inc., as Director-Commercial Strategy & Analytics from 2008 to 2011, Piper Sandler & Co. (Broker), as Senior Research Analyst, ThinkEquity Partners, as Senior Research Analyst, GC Royalty Holdings LLC, as Chief Financial Officer from 2016 to 2017, J.P.
Morgan & Co., Inc. (Old), as Research Associate, Senti Biosciences, Inc., as CFO, Treasurer & Head-Corporate Development from 2021 to 2024, and Ampio Pharmaceuticals, Inc., as Chief Business Officer from 2011 to 2012.
Dr. Knobelman received her undergraduate degree from Duke University and doctorate degree from the University of Pennsylvania Medical Center.

Deborah Knobelman active positions

Companies	Position	Start
Senti Sub I, Inc. Senti Sub I, Inc. BiotechnologyHealth Technology Develops novel therapeutics	Director of Finance/CFO	2021-04-30

All active positions of Deborah Knobelman

Former positions of Deborah Knobelman

Companies	Position	End
KRONOS BIO, INC.	Chief Executive Officer	2025-06-19
Senti Biosciences, Inc. Senti Biosciences, Inc. BiotechnologyHealth Technology Develops a synthetic biology platform that enables to program next-generation cell and gene therapies	Director of Finance/CFO	2024-05-02
GC Royalty Holdings LLC GC Royalty Holdings LLC Pharmaceuticals: GenericHealth Technology Develops and markets generic drugs	Director of Finance/CFO	2017-06-30
AMPIO PHARMACEUTICALS, INC.	Corporate Officer/Principal	2012-03-31
PFIZER INC.	Corporate Officer/Principal	2011-07-31

See the detail of Deborah Knobelman's experience

Training of Deborah Knobelman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Deborah Knobelman's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Pfizer Inc. Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients	Health Technology
Piper Sandler & Co. (Broker) Piper Sandler & Co. (Broker) Investment Banks/BrokersFinance Provides brokerage services	Finance
ThinkEquity Partners ThinkEquity Partners Investment ManagersFinance Provides investment advice and security brokerage services	Finance
GC Royalty Holdings LLC GC Royalty Holdings LLC Pharmaceuticals: GenericHealth Technology Develops and markets generic drugs	Health Technology
Duke University Duke University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
J.P. Morgan & Co., Inc. (Old) J.P. Morgan & Co., Inc. (Old) Regional BanksFinance Provides commercial banking and investment advisory services	Finance
Ampio Pharmaceuticals, Inc. Ampio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops immuno modulatory therapies for the treatment of pain from osteoarthritis	Health Technology
University of Pennsylvania Medical Center University of Pennsylvania Medical Center Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Senti Sub I, Inc. Senti Sub I, Inc. BiotechnologyHealth Technology Develops novel therapeutics	Health Technology
Kronos Bio, Inc. Kronos Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cancer therapeutics	Health Technology
Senti Biosciences, Inc. Senti Biosciences, Inc. BiotechnologyHealth Technology Develops a synthetic biology platform that enables to program next-generation cell and gene therapies	Health Technology